Beyond the Disease: Addressing Hair Loss in Cancer Care

When patients start chemotherapy, doctors usually prepare them for side effects and prescribe medications to help manage them. Zofran for nausea, Naproxen for headaches, Famotidine for stomach discomfort, and the list goes on.

Modern oncology recognizes that managing side effects is essential for helping patients tolerate treatment and maintain quality of life. But there is one side effect patients are warned about and often left to face alone: chemotherapy-induced alopecia (CIA).

Hair loss can be one of the most visible and emotionally challenging aspects of cancer treatment. It can impact identity, confidence, and privacy, turning a deeply personal experience into something the world can see

Yet historically, it has often been dismissed as “just cosmetic.”

Cancer care should treat the whole human being, not just the disease. Nausea, headaches, and stomach discomfort are all managed because they impact how patients feel during treatment. Hair loss deserves the same level of attention.

As oncology continues to evolve, we believe supportive care must evolve with it. Addressing chemotherapy-induced alopecia is part of treating patients with the dignity, compassion, and comprehensive care they deserve.

—-----------------------------------------------------------------------------------------------

Cooler Heads provides scalp cooling to cancer patients across the United States. This article is for informational purposes only. Please consult your oncologist before making any decisions about your treatment. Amma is an innovative, FDA-cleared scalp cooling device designed to help minimize hair loss in adult cancer patients (21+) undergoing treatment for solid tumors